← Eichor
Study identifier: NCT03248284 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons

Condition: Psoriatic Arthritis · Enthesitis  ·  Sponsor: Odense University Hospital

PhaseN/A
Planned participants30
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

Tendon pathologies (enthesitis) are a characteristic component of psoriatic arthritis (PsA), and are observed in 35% to 50% of PsA patients. The Achilles tendon is one of the most commonly affected sites. This condition often causes great morbidity and loss of quality of life, and response only suboptimal to current intervention strategies. One of the main obstacles for the development of effective treatment methods is that the disease mechanisms remain poorly understood. To our knowledge, no one has yet ascertained the presence and function of immune-competent cells and inflammatory markers in tendons tissue from PsA patients suffering from Achilles enthesitis.

This description comes directly from the study's public registry record.

Talk to the study team

Maja S. Kragsnaes, MD PhDfellow  ·  + 45 23238663  ·  maja.kragsnaes@dadlnet.dk

Torkell J. Ellingsen, Prof MD PhD  ·  torkell.ellingsen@rsyd.dk

Always discuss trial participation with your own doctor first.

Locations (2)

Odense University HospitalOdense, DenmarkRecruiting
Diagnostic CenterSilkeborg, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03248284